Net Sales Increase 13% to $50.1 Million

AngioDynamics, Inc. (ANGO)

F1Q10 Earnings Call

October 6, 2009 4:30 pm ET

Complete Story »

Question-and-Answer Session Operator Operator Instructions Our first question comes from the line of Christopher Warren with Caris & Company. Christopher Warren - Caris & Co. Thanks so much and it’s very gratifying to see you guys above the consensus for the quarter. My question is to what extent...

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4999072 for the full story.

C.R. Bard, Inc. (BCR) yesterday reported strong third quarter fiscal 2009 results after the market close. Earnings per share were $1.31, surpassing the Zacks Consensus Estimate of $1.27 and the year-ago earnings of $1.09. Sales Net sales in the quarter increased 3% year over year to $637.0 million. Excluding an unfavorable foreign currency translation (FX), net [...]

(BCR) C.R. Bard Surpasses Consensus Estimates

AngioDynamics, Inc. (ANGO) yesterday reported first quarter fiscal 2010 earnings per share of 9 cents, surpassing the Zacks Consensus Estimate of 8 cents. Earnings per share in the year-ago quarter also reached 9 cents. Sales Net sales in the reported quarter were $50.1 million, increasing 13% year over year. The increase was across all the business segments. [...]

(ANGO) AngioDynamics Outperforms Estimates

Stocks and commodities gained after the Bank of Australia became the first Group of 20 central bank to raise interest rates and ahead of a fresh round of earnings reports that bulls are betting will show better revenues confirm an improving corporate climate.[More...]